Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence

28 Sept 2024

Abstract excerpt

BACKGROUND: Despite reassuring clinical and histological features, low-grade meningiomas can recur after surgery. Targeted gene expression profiling improves risk stratification of meningiomas, but the utility of this approach for clinical low-risk meningiomas is incompletely understood. METHODS: This was a multicenter retrospective cohort study of meningiomas from patients who were treated at 4 institutions from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Meningioma and schwannoma management
Share to Pituitary Gland Disorders and Treatments
Share to Thyroid and Parathyroid Surgery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39340366
DOI: 10.1093/neuonc/noae198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A targeted gene expression biomarker predicts clinic low-risk meningioma recurrencePMID 39340366Read ↗

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesSemantic proximity Read ↗

Predictors of early recurrence in meningiomaSemantic proximity Read ↗

Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapiesSemantic proximity Read ↗

Genomic markers of recurrence risk in atypical meningioma following gross total resectionSemantic proximity Read ↗

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical managementSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeSemantic proximity Read ↗

Risk Factors and Genomic Characteristics of Recurrent Meningiomas Identified Through Routine Clinical TestingSemantic proximity Read ↗

Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA ProfilingSemantic proximity Read ↗

Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeSemantic proximity Read ↗

Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical OutcomeSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.